Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07441083 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness
A NA study, sponsored by SF Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07441083 is a NA study that is actively recruiting participants, run by SF Research Institute. The registered enrollment target is 60 participants.
The verdict
NCT07441083, a NA study, is actively recruiting participants, sponsored by SF Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This randomized, double-blind, placebo-controlled clinical study is designed to evaluate the efficacy and safety of a standardized Shatavari (Asparagus racemosus) root extract (SRI-81) in improving women's sexual wellness. Sexual wellness is assessed as a multidimensional construct encompassing sexual function, sexual distress, sexual satisfaction, perceived stress, quality of life, and physiological stress markers. Participants will receive either Shatavari root extract or placebo for 12 weeks, with assessments conducted at baseline and follow-up visits.
Interventions
- OTHER Placebo Capsule
- DIETARY_SUPPLEMENT Shatavari (Asparagus racemosus) Root Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-04-29 |
| Est. Completion | 2026-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07441083
The ClinicalTrials.gov registry entry for NCT07441083 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SF Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Capsule is the first listed.
NCT07441083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07441083 about?
NCT07441083 is a clinical study titled "Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness". This randomized, double-blind, placebo-controlled clinical study is designed to evaluate the efficacy and safety of a standardized Shatavari (Asparagus racemosus) root extract (SRI-81) in improving women's sexual wellness. Sexual wellness is assessed as a multidimensional construct encompassing sexu...
What is the current status of trial NCT07441083?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-04-29. Estimated completion is 2026-08-15.
What interventions are being tested in trial NCT07441083?
The interventions under investigation include: Placebo Capsule (OTHER), Shatavari (Asparagus racemosus) Root Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07441083?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.